0001127602-23-028095.txt : 20231120 0001127602-23-028095.hdr.sgml : 20231120 20231120211446 ACCESSION NUMBER: 0001127602-23-028095 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231116 FILED AS OF DATE: 20231120 DATE AS OF CHANGE: 20231120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farrell Michael J. CENTRAL INDEX KEY: 0001485164 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-15317 FILM NUMBER: 231424305 MAIL ADDRESS: STREET 1: C/O REMED INC STREET 2: 9001 SPECTRUM CTR. BLVD. CITY: SAN DIEGO, STATE: CA ZIP: 92123 FORMER NAME: FORMER CONFORMED NAME: Farrell Michael DATE OF NAME CHANGE: 20100224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RESMED INC CENTRAL INDEX KEY: 0000943819 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 980152841 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 BUSINESS PHONE: 8587462400 MAIL ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 4/A 1 form4a.xml PRIMARY DOCUMENT X0508 4/A 2023-11-16 2023-11-20 0000943819 RESMED INC RMD 0001485164 Farrell Michael J. RESMED INC. 9001 SPECTRUM CENTER BLVD SAN DIEGO CA 92123 1 Chief Executive Officer 0 ResMed Common Stock 4090 I Lisette and Michael Farrell Family Trust ResMed Common Stock 2023-11-16 4 M 0 3462 57.76 A 444448 D ResMed Common Stock 2023-11-16 4 F 0 1343 148.90 D 443105 D ResMed Common Stock 2023-11-20 4 F 0 2352.929 148.94 D 440752 D ResMed Common Stock Options 57.76 2023-11-16 4 M 0 3462 0 D 2017-11-11 2023-11-16 ResMed Common Stock 3462 0 D ResMed Common Stock Options 148.90 2023-11-16 4 A 0 55468 148.90 A 2024-11-11 2030-11-16 ResMed Common Stock 55468 55468 D Original form amended to include a plan provision auto-exercise prior to option grant expiration. Disposition to issuer for exercise cost of options auto-exercised under the plan. Disposition to issuer for tax withholding on vesting of Performance Restricted Stock Units granted on 11/19/2020. Transaction was a plan auto exercise prior to expiration. Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2024, 2025, and 2026. Michael J. Farrell, Chief Executive Officer 2023-11-20